Company Filing History:
1 out of 3,923 
1 out of 159 
1 out of 100 Years Active: 2018-2022
Title: The Innovative Journey of Inventor Xiao Luo in Shanghai
Introduction
Xiao Luo, an esteemed inventor based in Shanghai, China, has significantly contributed to the field of pharmaceuticals with his innovative inventions. With a total of two patents, Luo's work primarily focuses on developing advanced therapeutic solutions aimed at combating cancer and enhancing medical treatment.
Latest Patents
Xiao Luo's recent patents showcase his dedication to medical advancements. The first patent, titled "Fusion protein containing TGF-β receptor and medicinal uses thereof," introduces a novel fusion protein that includes TGF-β receptor, emphasizing its pharmaceutical applications. This invention also describes a bifunctional fusion protein that comprises a PD-L1 antibody targeting portion and the extracellular domain of TGF-βRII. It notably involves a pharmaceutical composition that utilizes this fusion protein for the development of anti-cancer drugs.
The second patent, "Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor," explores isolated antibodies and antigen-binding fragments that specifically bind to human BMP9. This invention also outlines various compositions and methods for their application, highlighting Luo's innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Xiao Luo has collaborated with leading pharmaceutical companies, including Novartis AG and Jiangsu Hengrui Medicine Company Ltd. These experiences have empowered him to refine his inventions and bring them closer to practical medical applications.
Collaborations
In his pursuit of medical innovation, Luo has worked alongside talented individuals such as Zijun Chen and Sujun Deng. These collaborations have fostered an environment of creativity and innovation, leading to impactful advancements in therapeutic research.
Conclusion
Xiao Luo's contributions to the field of medicine through his patents are a testament to his innovative spirit and dedication. With his work addressing critical needs in cancer treatment, he continues to inspire the next generation of inventors and researchers. The path he has paved not only showcases his expertise but also emphasizes the importance of collaboration in driving medical progress.